David M Parry

US Patent:

8221129, Jul 17, 2012

Filed:

Jun 3, 2008

Appl. No.:

12/131980

Inventors:

David Parry - Yardley PA, US
Daniel Parry - Dublin PA, US
Daniel Pipito - Feasterville PA, US
Brian Letizia - Brick NJ, US
Morris Ravich - Beckley WV, US
Daniel Smith - Hatboro PA, US

Assignee:

Techline Technologies, Inc. - Willow Grove PA

International Classification:

G09B 23/28

US Classification:

434272, 434274

Abstract:

A wearable wound simulant including a skin replica having the appearance of a particular region of the human body, examples including but not limited to a leg, arm, torso, or stomach, and a wound disposed along the skin replica is described. The skin replica includes a plurality of bendable layers arranged to replicate the visual and tactile properties of human tissues and at least one tear resistant layer comprised of a fabric material disposed between two bendable layers. The tear resistant layers are less stretchable than the bendable layers so as to prevent the bendable layers from stretching beyond their failure threshold. Design elements of the present invention facilitate the visual, tactile, and functional aspects of a battlefield wound so as to allow for the diagnosis of injuries associated therewith. Furthermore, the present invention allows for the insertion of a needle or the like, the probing and/or packing of wounds, the compression of vascular simulants to stop or limit blood loss, and the replacement of dislodged organs.

US Patent:

8491309, Jul 23, 2013

Filed:

Jun 26, 2012

Appl. No.:

13/532848

Inventors:

David Parry - Yardley PA, US
Daniel Parry - Dublin PA, US

Assignee:

Techline Technologies, Inc. - Willow Grove PA

International Classification:

G09B 23/28

US Classification:

434272

Abstract:

A wearable wound simulant for simulating a battlefield wound is presented. The simulant facilitates a graphically and functionally realistic medical training tool. The simulant includes a skin replica and a wound. The skin replica is shaped to conformably contact and cover a body region either in part or whole. The skin replica further includes a plurality of bendable layers arranged to approximately replicate the visual and tactile properties of human tissue and at least one tear resistant layer composed of a fabric material disposed between two bendable layers. At least one tear resistant layer is less stretchable than the elastic limit of the bendable layers so as to prevent failure thereof. The bendable and tear resistant layers form a self-sealing structure. A three-dimensional wound structure is disposed along the skin replica so as to replicate the appearance and functionality of a penetrating or non-penetrating injury.

US Patent:

20070082900, Apr 12, 2007

Filed:

Oct 4, 2006

Appl. No.:

11/542801

Inventors:

Timothy Guzi - Chatham NJ, US
Kamil Paruch - Garwood NJ, US
Michael Dwyer - Scotch Plains NJ, US
David Parry - Mountain View CA, US

International Classification:

A61K 31/5377
A61K 31/519

US Classification:

514234500, 514252160, 514259300

Abstract:

The present invention provides methods for inhibiting protein kinases selected from the group consisting of AKT, Checkpoint kinase, Aurora kinase, Pim kinases, and tyrosine kinase using pyrazolo[1,5-a]pyrimidine compounds and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with protein kinases using such compounds.

US Patent:

20070105864, May 10, 2007

Filed:

Nov 8, 2006

Appl. No.:

11/598188

Inventors:

Timothy Guzi - Chatham NJ, US
Kamil Paruch - Garwood NJ, US
Michael Dwyer - Scotch Plains NJ, US
David Parry - Mountain View CA, US
Lianyun Zhao - Burlington MA, US
Patrick Curran - Winthrop MA, US
David Belanger - Cambridge MA, US
Blake Hamann - Watertown MA, US
Panduranga Reddy - Walpole MA, US
M. Siddiqui - Newton MA, US
Praveen Tadikonda - Norwood MA, US

International Classification:

A61K 31/498

US Classification:

514249000

Abstract:

The present invention provides methods for inhibiting protein kinases selected from the group consisting of AKT, Checkpoint kinase, Aurora kinase, Pim-1 kinase, and tyrosine kinase using imidazo[1,2-a]pyrazine compounds and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with protein kinases using such compounds.

US Patent:

20100286038, Nov 11, 2010

Filed:

Sep 16, 2008

Appl. No.:

12/678320

Inventors:

Valentyn Antochshuk - Cranford NJ, US
Anita Dabbara - Princeton Junction NJ, US
Paul Kirschmeier - Basking Ridge NJ, US
David A. Parry - Mountain View CA, US
Mohammed Shameen - Nanuet NJ, US

International Classification:

A61K 38/18
A61K 31/519
A61P 35/02
A61P 35/00

US Classification:

514 76, 5142593

Abstract:

This application discloses a novel formulation containing a 3-amino-4-substituted pyrazole derivative which has cyclin-dependent kinase inhibiting properties, and a method of treating tumors using the novel formulation.